BIOMAT Database Logo BIOMAT Database Logo

[Radioreceptor assay of serum psychotropic drug levels]. 1983

K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
A novel and sensitive radioreceptor assay for serum melatonin levels.
January 1991, Life sciences,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Radioreceptor assay for serum levels of cetamolol, a new beta-adrenoceptor antagonist.
June 1984, Clinical biochemistry,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Determination of serum hCG levels by radioreceptor assay in the clinical laboratory.
September 1979, The American journal of medical technology,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
A radioreceptor assay for serum insulin.
October 1977, The Journal of laboratory and clinical medicine,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
February 1980, The American journal of psychiatry,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Radioreceptor assay of narcotic analgesics in serum.
September 1984, Pharmaceutical research,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Monitoring of serum bioactivity levels of perazine and its metabolites by radioreceptor assay.
May 1989, Pharmacopsychiatry,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations.
July 1979, Psychiatry research,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.
January 1986, Psychopharmacology,
K Sarai, and T Nakahara, and K Nakagawa, and M Yoshihara
Serum effects confound the neuroleptic radioreceptor assay.
March 1984, Life sciences,
Copied contents to your clipboard!